Press Releases & Presentations

Press Releases & Presentations

Date Title and Summary Additional Formats
Toggle Summary Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
TUCSON, Ariz. , Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016 . President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Financial Officer, will host Read more
View HTML
Toggle Summary Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8
TUCSON, Ariz. , July 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report second-quarter 2016 financial results on Monday, August 8 th . President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Financial Officer, will host a Read more
View HTML
Toggle Summary Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit
TUCSON, Ariz. , July 11, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the submission of a De Novo request for Evaluation of Automatic Class III Designation to the U.S. Food and Drug Administration (FDA) for its Accelerate Pheno™ system and Accelerate Read more
View HTML
Toggle Summary William Blair & Company 36th Annual Growth Stock Conference View HTML
Toggle Summary Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference
TUCSON, Ariz. , June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the completion of clinical data collection intended for submission to the FDA in conjunction with its de novo 510k request for premarket clearance of the Accelerate Pheno™ system and Read more
View HTML
Toggle Summary Accelerate Diagnostics to Present at the 36th Annual Growth Stock Conference
TUCSON, Ariz. , June 07, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren , the company's president and chief executive officer, is scheduled to present to investors at the 36 th Annual Growth Stock Conference hosted by William Blair & Company, L.L.C. Read more
View HTML
Toggle Summary Accelerate Diagnostics Schedules First-Quarter 2016 Results Announcement and Webcast
TUCSON, Ariz. , April 25, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report first-quarter 2016 financial results after market close on Thursday, May 12, 2016 . President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Financial Read more
View HTML
Toggle Summary Accelerate Diagnostics to Present Data at European Congress
TUCSON, Ariz. , April 10, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today it will present data related to the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for positive blood cultures while attending the European Congress of Clinical Microbiology and Read more
View HTML
Toggle Summary Investor Overview
Investor Overview Read more
View HTML
Toggle Summary District Court Dismisses Lawsuit Against Accelerate Diagnostics
TUCSON, Ariz. , Jan. 29, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) ("Accelerate Diagnostics") announced today that the United States District Court for the District of Arizona granted Accelerate Diagnostics' Motion to Dismiss the class action lawsuit filed against it in Read more
View HTML
:

Day High:
Day Low:  
Volume:    

Copyright Nasdaq. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates